Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
76-90 of 2220 results
Galenica completes acquisition of Relypsa
Galenica Group announced the completion of its previously announced acquisition of Relypsa.
Production & Manufacturing > Manufacturing > News
Allergan and Adamas settle NAMZARIC patent litigation with Amneal
Allergan announced that its subsidiaries Forest Laboratories LLC, Forest Laboratories Holdings, Ltd. and Allergan USA, along with Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York, LLC.
Production & Manufacturing > Manufacturing > News
BioInvent extends manufacturing services contract with global pharmaceutical client
BioInvent International has signed an extended contract for manufacturing services with one of its current customers, a major global pharmaceutical client.
Production & Manufacturing > Manufacturing > News
AstraZeneca to sell part of antibiotics business to Pfizer in $1.6bn deal
By PBR Staff Writer
AstraZeneca has agreed to sell part of its antibiotics business to Pfizer in a deal worth about $1.6bn.
Production & Manufacturing > Manufacturing > News
Fresenius Kabi to invest $250m to expand pharmaceutical manufacturing facility in US
By PBR Staff Writer
Health care firm Fresenius Kabi is set to invest around $250m to expand its pharmaceutical manufacturing facility in Melrose Park, Illinois, US.
Production & Manufacturing > Manufacturing > News
Avacta opens two new facilities in Cambridge and Wetherby
Avacta Group, the developer of Affimer biotherapeutics and research reagents, has opened two new facilities, in Cambridge and Wetherby, Yorkshire.
Production & Manufacturing > Manufacturing > News
Endo decides to withdraw sNDA for OPANA ER
Endo International announced today that based on an August 11, 2016 discussion with the US Food and Drug Administration (FDA), it has decided to withdraw its supplemental New Drug Application (sNDA) relating to specific abuse deterrent labeling for OPANA ER without prejudice to re-filing.
Production & Manufacturing > Manufacturing > News
Jacobs wins contract for Novartis Pharma biotechnology center expansion in France
Jacobs Engineering Group has secured a contract to expand the Novartis Pharma Biotechnology Center in Huningue, France.
Production & Manufacturing > Manufacturing > News
Mylan completes Meda acquisition
Mylan has completed the settlement of its recommended public offer to the shareholders of Meda Aktiebolag (publ.) to tender all their shares in Meda to Mylan (the Offer).
Production & Manufacturing > Manufacturing > News
AbbVie files patent infringement suit over Amgen’s copy of Humira drug
By PBR Staff Writer
AbbVie has filed a patent infringement lawsuit, seeking to block Amgen from selling a copy of its Humira (adalimumab) rheumatoid arthritis drug.
Production & Manufacturing > Manufacturing > News
Jacobs wins contract for Alnylam's new manufacturing facility in Massachusetts
Jacobs Engineering Group has secured a contract to provide engineering services and procurement for Alnylam Pharmaceuticals’ new manufacturing facility in Norton, Massachusetts.
Production & Manufacturing > Manufacturing > News
EU clears Sanofi’s acquisition of Boehringer’s consumer health business
By PBR Staff Writer
French drug maker Sanofi has secured approval from the European Commission for its proposed acquisition of Boehringer Ingelheim’s consumer health business, subject to conditions.
Production & Manufacturing > Manufacturing > News
Avara to buy Astellas' US manufacturing subsidiary
Avara Pharmaceutical Services' subsidiary, Avara Norman Pharmaceutical Services has entered into an agreement under which Avara will acquire Astellas' wholly owned manufacturing subsidiary Astellas Pharma Technologies (APT), located in Norman, Oklahoma.
Production & Manufacturing > Manufacturing > News
Allergan sells global generics business to Teva Pharmaceuticals
Allergan has completed the divestiture of its global generic pharmaceuticals business to Teva Pharmaceutical Industries.
Production & Manufacturing > Manufacturing > News
Xbrane submits GMP approval application to Italy’s AIFA for production facility for Spherotide
By PBR Staff Writer
Xbrane Biopharma’s subsidiary Primm Pharma has submitted GMP approval application to the Italian Medicines Agency AIFA for its production facility for Spherotide located outside Naples, Italy.
Production & Manufacturing > Manufacturing > News
76-90 of 2220 results